• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

IDCases Oseltamivir and Baloxavir: Dual Treatment for Rapidly Developing ARDS on a Patient With Renal Disease

tetano

Editor, Senior Moderator
IDCases


. 2020 May 22;21:e00819.
doi: 10.1016/j.idcr.2020.e00819. eCollection 2020.
Oseltamivir and Baloxavir: Dual Treatment for Rapidly Developing ARDS on a Patient With Renal Disease


Pool Tobar Vega[SUP] 1 [/SUP], Elena Caldeira[SUP] 1 [/SUP], Hasan Abad[SUP] 1 [/SUP], Peguy Saad[SUP] 1 [/SUP], Erik Lachance[SUP] 1 [/SUP]



Affiliations
Free PMC article

Abstract

Influenza is an annual epidemic disease that in severe cases can lead to the development of ARDS. Current practice recommends the routine use of neuraminidase inhibitors with emerging evidence for the use of endonuclease inhibitors. We present the case of a 22-year-old female with diabetes and IgG4 tubulo-interstitial nephritis that developed rapidly progressive ARDS from influenza infection requiring ventilatory support and extra corporeal oxygenation in which oseltamivir and baloxavir were used in combination. Patient oxygen requirements and imaging improved significantly after treatment initiation, leading to an overall short period of therapy. We present the first case of a patient treated with this combination in the context of chronic kidney disease.
 
Back
Top Bottom